Omalizumab vs Oral Immunotherapy for Multiple Food Allergies: OUtMATCH Trial Explained

Hope & Histamine: The Paediatric Allergy Podcast · Oct 3, 2026 · 43m

How does omalizumab compare with oral immunotherapy for treating multiple food allergies? In this episode of Hope & Histamine: The Paediatric Allergy Podcast, we explore OUtMATCH Stage 2, comparing omalizumab (Xolair) with omalizumab-facilitated multi-allergen oral immunotherapy (OIT).

We unpack the findings on treatment success, allergic reactions, side effects and treatment discontinuation—and explain why tolerability matters when interpreting the results. What do these findings mean for children with peanut allergy and other food allergies, their families, and the clinicians supporting…